It was found that there is a correlation between IL-12 levels and an increased BARDI score (predictive score for fibrosis in NAFLD patients), which is based on BMI, AST/ALT, and the presence of diabetes [39]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.